Tracker-25 Infusion Catheter
Target Therapeutics
FDA Clearance Information
The tracker-25 infusion catheter was cleared by the FDA through the 510(k) pathway on February 12, 1988. It is manufactured by Target Therapeutics and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Percutaneous catheterization of blood vessels for diagnostic or therapeutic procedures.
- Delivery of fluids or medications through the vascular system when clinically indicated.
Clinical Applications
- Percutaneous vascular access during image-guided endovascular procedures.
- Infusion of medications or fluids into an accessed blood vessel.
- Catheter-based treatment procedures in which a small-caliber infusion catheter is required.
Reported off-label uses
- Selective catheter-directed thrombolysis or infusion during treatment of venous thromboembolism, when the treating physician determines that use is appropriate.
- Infusion during selected venous interventions, including some thrombectomy or venous-stenting procedures, when compatible with the catheter's labeling and specifications.
Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- Confirm the catheter's French size, length, lumen configuration, guidewire compatibility, and maximum injection pressure before use.
- Use sterile technique and fluoroscopic or other appropriate imaging guidance for vascular placement.
- Inspect the catheter before use for damage, kinking, or obstruction, and follow the manufacturer's instructions for flushing and infusion.
- MRI safety, including whether the catheter is MR Safe, MR Conditional, or MR Unsafe, should be confirmed from the current product labeling; the FDA record alone does not establish MRI status.
- Potential risks include bleeding, hematoma, infection, vessel injury, thrombosis, embolization, catheter fracture, and contrast-related complications.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for tracker-25 infusion catheter?
The tracker-25 infusion catheter is indicated for use in intravenous infusion procedures, particularly in venous-stent applications. Specific indications should be verified with FDA documentation.
What outcomes have been reported in clinical studies?
Studies report reduced central line-associated infections and improved infusion quality with the use of the tracker-25 infusion catheter.
What complications have been reported?
Safety data indicate risks of infiltration, extravasation, and catheter migration, particularly with vesicant medications.